T
he Wiskott-Aldrich syndrome (WAS) is an X-linked combined immunodeficiency affecting 1 in 300,000 live male births caused by mutations in the gene coding for WASp (1) . WASp is a member of the WASp͞Scar͞WAVE family of proteins expressed specifically in hematopoietic cells. It binds actin monomers as well as the actin-related protein (ARP) 2͞3 complex to catalyze branching of filamentous actin (F-actin) (2) . Mutations in WASp impairing its function result in reduced actin polymerization, filopodia formation, phagocytosis, and chemotaxis (3) . Children with WAS suffer from susceptibility to a variety of infections including those caused by herpesviruses as well as greatly increased incidence of malignancies (4) . Natural killer (NK) cells are lymphocytes lacking expression of T cell receptors and Ig that are capable of producing cytokines and mediating cytolysis after being activated through germ-lineencoded receptors. NK cells use these activities to play important roles in antiviral defense and tumor surveillance (5) . NK cells also express inhibitory receptors, e.g., the killer cell Ig-like receptor (KIR) family, that are capable of curtailing NK cell functions after ligation. Naturally occurring human deficiencies of NK cells or NK cell activity have been reported but are rare (6) . Advances in the understanding of human primary immunodeficiency and identification of single gene defects as etiologies will provide opportunities to elucidate specific pathways in NK cell function. In this light, quantification of NK cell activity in peripheral blood mononuclear cell (PBMC) populations from WAS patients has yielded mixed results, with occasional reports of deficits in cytotoxic activity (7) (8) (9) (10) . However, the activities of isolated NK cells from patients with WAS have not been evaluated.
NK cell activation appears to require function of the actin cytoskeleton, as does T cell activation (11) . Early work has shown that actin is polymerized in NK cells encountering susceptible, but not resistant, target cells and that inhibitors of actin polymerization interfere with cytolytic function (12, 13) . More recent studies with immortalized NK cell tumor lines or NK cells propagated in vitro with IL-2 have shown that a variety of signaling molecules as well as lipid rafts and the cytoskeletal attachment protein, talin, localize to the activating NK cell immunologic synapse (IS) (14) (15) (16) . Although there are similarities between the NK cell-activating and inhibitory IS (17, 18) , molecules accumulate with different kinetics and lipid rafts are excluded from the inhibitory IS (14, 15, 18) . Furthermore, KIRs and KIR signaling are essential to the inhibitory IS, and KIR accumulation does not require ATP or actin polymerization (15, 17) . In contrast, raft polarization in NK cell-activating interactions is necessary for cytotoxicity (14) and requires actin polymerization as evidenced by its sensitivity to cytochalasin D (Cyt-D) (15) . However, the roles of specific regulators of cytoskeletal formation including WASp have not been investigated in NK cell functional interactions.
Methods
Patients and Control Donors. Diagnosis of WAS was based on the presence of established clinical findings (4) and mutation in the WASP gene. WASP sequence analysis was performed as described (19) (20) (21) . Pre-bone marrow transplant immunophenotypes of all WAS patients diagnosed and treated at Children's Hospital between 1992 and 2002 were reviewed retrospectively. PBMC were evaluated by flow cytometry in the Children's Hospital Clinical Immunology Laboratory by using FITC-anti-CD3, PE-anti-CD56, and PE-anti-CD16 (Becton Dickinson). When these reagents are used, NK cells are PE Further studies were performed with whole blood from patients 1 and 2. Patient 1 had thrombocytopenia, recurrent otitis media, cellulitis, and severe eczema. Patient 2, the younger brother of patient 1, was diagnosed postnatally and had not experienced infectious complications. Both patients were treated every 3 weeks with 500 mg͞kg i.v. Ig. All studies were performed with informed consent and the approval of the Children's Hospital Committee on Clinical Investigation.
Control donors were healthy adolescents or adults and had a similar range of NK cell cytotoxicity as would individuals specifically age-matched to WAS patients 1 and 2 (22 and double-stranded cDNA was synthesized and transcribed as biotin-labeled cRNA, which was hybridized to Human Genome U95Av2 GeneChip Arrays (Affymetrix, Santa Clara, CA) and prepared further according to the manufacturer's recommendations. Analysis of hybridization was performed by using NetAffyx and MICROARRAY 5.0 software (Affymetrix). For Western blotting, PBMC or NK cell preparations were lysed in 1% Nonidet P-40 lysis buffer and 20 g protein separated on a 10% polyacrylamide gel. Proteins were transferred to nitrocellulose membranes, which were incubated with murine anti-WASp mAb 5A5 (23) . Bound antibody was detected with peroxidase-conjugated goat-anti-mouse (Jackson ImmunoResearch) and enhanced chemiluminescence detection system (Amersham Pharmacia). ) in RPMI-CM were placed in each well of a 96-well, round-bottomed polystyrene plate (Corning), mixed with NK cells at specified effector-to-target cell ratios and incubated for 4 h at 37°C. 51 Cr released into supernatants (experimental cpm) was measured with a Lumiplate and TopCount XL gamma detector (Packard). Percentage lysis was calculated as follows: (exp. cpm Ϫ spontaneously released cpm)͞(total cpm Ϫ spontaneously released cpm). Total cpm were assessed by complete lysis of target cells by using 1% Nonidet P-40 in water. Lytic units were defined as the number of effector cells required to mediate 20% lysis of target cells expressed as the inverse normalized to 1 ϫ 10 4 cells and were calculated by using the slopes of curves generated by 51 Cr-release assay over the range of effector-to-target cell ratios. For experiments using Cyt-D-and DMSO-treated cells, cytotoxicity assay was performed in the presence of 5 M Cyt-D͞0.05% DMSO or 0.05% DMSO, respectively.
Confocal Microscopy. NK cell͞target cell conjugates were formed by suspending NK effector cells at 5 ϫ 10 6 ͞ml and K562 erythroleukemia target cells at 2.5 ϫ 10 6 ͞ml in RPMI-CM. Equal volumes of effector and target cell suspensions were mixed and incubated for 15 min at 37°C. When cells were first pretreated with Cyt-D or DMSO, conjugates were allowed to form in the presence of 5 M Cyt-D͞0.05% DMSO or 0.05% DMSO, respectively. NK cells or NK cell͞K562 cell conjugates were resuspended gently and 60 l was incubated on Polyprep microscope slides (Sigma) for 15 min at 37°C. Slides were rinsed in 2ϫ PBS, and adherent cells were fixed and permeabilized with 4% formaldehyde, 0.1% saponin, and 0.1% Triton X-100 in PBS for 15 min. Slides were washed in 2ϫ PBS with 0.1% saponin (PBS-s) and incubated for 1 h with anti-WASp mAb, with control mouse IgG2a clone MOPC31 (Becton Dickinson) used as a control. Slides were washed with 2ϫ PBS-s, incubated for 1 h with ALEXA-568-conjugated, highly cross-adsorbed goat-antimouse (Molecular Probes), washed with 2ϫ PBS-s, and incubated with 10% heat-inactivated mouse serum (Sigma) for 30 min to block subsequent-nonspecific binding. After two PBS-s washes, murine FITC-anti-perforin IgG2b or FITC-IgG2b control (Becton Dickinson) was added with or without ALEXA-647-conjugated phalloidin (Molecular Probes) or ALEXA-647-conjugated streptavidin (as a negative control) for 1 h. Slides were washed with 2ϫ PBS-s, covered with 0.15-mm glass coverslips (VWR Scientific), and mounted with cytoseal (Richard-Allan Scientific, Kalamazoo, MI). All antibodies were used in the range of 0.2-20 g͞ml.
Images were acquired with a Zeiss LSM 510 confocal microscope To determine whether the presence of WASp mRNA correlates with detectable levels of WASp, Western blotting was performed with cell lysates from enriched peripheral blood NK cells. High levels of WASp protein were detected easily in PBMC as well as in NK cells prepared from the same healthy individual (Fig. 1, P1 and N1). Similar levels of WASp also were found in NK cells prepared from other normal donors (Fig. 1, N2 and N3 ). Although WASp expression can be variable in PBMC from WAS patients (20), WASp was not detectable in NK cells from WAS patients 1 and 2 ( Fig. 1, W1 and W2) . Culture of patient NK cells in 500 units͞ml IL-2 for 3 weeks failed to reverse this finding (data not shown). Thus, WASp was expressed and produced in normal NK cells but was absent in two WAS patient NK cells.
Increased NK Cell Populations with Deficient Cytotoxic Activity in

WAS.
Previous reports of NK cell cytolytic activity in total PBMC from WAS patients have not yielded consistent deficiencies (7-9). To determine whether the observed heterogeneity might be a result of expanded NK cell populations in WAS patients, the immunophenotype of all patients treated at Children's Hospital in the past decade was reviewed. The frequency of NK cells was evaluated before bone marrow transplantation in nine patients diagnosed with WAS who had demonstrable mutation in the WASP gene ( Table 1 ). The mean percentage of NK cells in PBMC from WAS patients was elevated significantly as compared with age-specific means for healthy children (24) . In addition, mean NK cell percentages of WAS patients were Ϸ2 SD above the age mean. The increased percentages of peripheral blood NK cells in WAS patients may account for heterogeneity in cytotoxic activity previously observed in WAS patient total PBMC.
To determine whether NK cells in WAS patients have an intrinsic defect in cytolytic activity, two patients who had not yet received a bone marrow transplant were studied in greater detail. PBMC from patients 1 and 2 were assessed for NK cell cytotoxicity against K562 target cells and were found to have activity present (data not shown). To more accurately investigate NK cell activity on a per cell basis, NK cells were enriched by negative selection and evaluated for lysis of K562 cells. When similarly pure populations of NK cells were used from control donors and WAS patients, NK cell cytotoxicity was decreased significantly in both boys with WAS ( Fig.  2A) . A severe deficit in activity of enriched NK cells also was reflected in lytic units: WAS patients 1 and 2 only had 17% and 16% of controls, respectively (Fig. 2B) . Thus, NK cell cytotoxicity is defective in WAS. The low activity may be compensated by increases in the PBMC NK cell populations.
WASp and F-Actin Colocalize to the Activating NK Cell IS. F-actin is known to accumulate at contact points between NK cells and susceptible target cells (12) . Because NK cell cytotoxicity was deficient in WAS patients and WASp catalyzes actin polymerization, localization of WASp in healthy donor NK cells forming an activating IS was examined. In freshly isolated normal NK cells, both F-actin and WASp were visualized at the NK cell side of the interface with K562 target cells by laser-scanning confocal microscopy (Figs. 3 and 4A ). F-actin and WASp accumulated at the activating IS in 82% and 72% of NK cell͞target cell conjugates, respectively (Fig. 3) . When F-actin was located at the IS, WASp was found to colocalize 86% of the time. Perforin also could be visualized in conjugated NK cells and was found either at the NK cell IS along with F-actin and WASp (Fig. 4A) or at some other location in the cell (Fig. 4B) . Perforin was found only at the IS in 43% of conjugates (Fig. 3) . Similarly, when F-actin was found at the IS, perforin also was there 50% of the time. Three-dimensional reconstruction of the NK cell IS with accumulated F-actin and WASp by using Z sections routinely demonstrated colocalization of the two molecules (Fig. 4C) . When present at the IS, perforin only colocalized with part of the F-actin͞WASp complex. Thus, F-actin and WASp were located in the vast majority of NK cell-activating IS, and perforin was present at the IS in a subset.
Cyt-D Inhibits NK Cell Cytotoxicity as Well as Actin and WASp Accu-
mulation at the Activating NK Cell IS. The importance of actin polymerization on and its role in WASp localization to the NK cell-activating IS was investigated by using Cyt-D as a polymerization inhibitor. Cyt-D previously has been demonstrated to prevent NK cell cytotoxic activity (13) . Pretreatment of fresh control donor NK cells with Cyt-D for 30 min completely inhibited lytic activity (Fig. 2C) , as reported previously. Treatment of cells with DMSO (the solvent for Cyt-D) did not affect NK cytotoxicity. Microscopically, DMSO-treated cells had a normal appearance of the activating NK cell IS (Fig. 5A) , but Cyt-D-treated cells had discontinuous F-actin and WASp and synaptic accumulation was not seen (Fig. 5B) . In DMSO-treated cells, F-actin and WASp were accumulated at the IS in 79% and 71% of conjugates, whereas in Cyt-D-treated cells they were accumulated in only 27% and 17% of conjugates (Fig. 3) . Perforin accumulation also was decreased in conjugates formed with Cyt-D-compared with DMSO-treated NK cells, suggesting that this process depends on effective actin polymerization as well. Thus, actin polymerization is required for NK cell cytotoxic activity and accumulation of WASp and perforin at the activating IS.
Actin Accumulation at the NK Cell-Activating Synapse Is Decreased in WAS Patients. Although defective actin polymerization is a hallmark of WAS, this process has not been evaluated in NK cells of patients with WASp mutations. In addition, a requirement for WASp in perforin mobilization is unknown. To address these questions, WAS patient NK cells were evaluated by laser-scanning confocal microscopy. Patient NK cells were strikingly different from control because they lacked detectable WASp and appeared to have only faint rings of F-Actin (Fig. 5 C and D) . Perforin staining, however, was robust and similar to controls. WASp was not induced in patient NK cells conjugating with K562 cells, and F-actin failed to accumulate at the NK cell IS (Fig. 5E ). F-actin and perforin were found at the IS in only 27% and 16% of conjugates (Fig. 3) . Thus, similar to Cyt-D treatment, patients with WAS have strikingly decreased or absent F-actin accumulation and proportionally decreased perforin accumulation at the NK cell IS. Furthermore, polarization of perforin granules depended on effective WASp-driven actin polymerization.
Discussion
In the few studies of NK cells in WAS reported, some patients had normal and others had deficient K562 killing (4, 7, 9, 10) .
The observed variability appears to be a result of increased NK cell percentages in PBMC (Table 1) , because isolated NK cells from two WAS patients were defective on a per cell basis (Fig.  2) . In murine models and humans with NK cell deficiencies, NK cells are important in the defense against herpesviruses (25) . The preponderance of herpesgroup virus infections in WAS patients, including a disproportionate number of invasive, recurrent, and drug-resistant occurrences (4, 26, 27) , can be understood in this light. Furthermore, children with WAS have an extraordinarily high rate of malignancies (4) that may be related to a role of NK cells in tumor cell surveillance (5) . Thus, the functional defects found in WAS patient NK cells appear to be clinically significant.
WASp was expressed in normal NK cells (Fig. 1 ) and was located diffusely near the surface of normal unactivated NK cells (Fig. 5) . After interaction with a susceptible target cell, WASp accumulated at the activating IS with F-actin (Figs. 3 and 4) . This localization was required for functional activating IS formation and cytotoxic activity, as shown both by Cyt-D treatment of normal NK cells and by studies of WAS patients deficient in WASp. The signals required for WASp targeting to membrane activation domains also are being investigated in T cells (28, 29) . Because of the differences in signaling cascades on activation of T cells and NK cells, pathways leading to WASp localization and function in these two cell types could be distinct. Pursuit of WASp regulation in NK cells, therefore, may provide hitherto unappreciated mechanisms of WASp localization.
The nature of both the inhibitory and activating human NK cell IS continues to be elucidated structurally, spatially, and temporally (14) (15) (16) (17) (18) . In addition to WASp and F-actin, talin accumulates at the NK cell-activating IS and forms a variety of three-dimensional arrangements (16) . Moreover, rearrangement at the NK cell IS occurs with great speed (18) . These studies, however, used IL-2-driven NK cell cultures. To avoid the effect of activating factors required for in vitro propagation that have well known and potent effects on NK cells, the present studies used freshly isolated NK cells. In vivo treatment of a WAS patient and stimulation of WAS patient lymphocytes in vitro with IL-2 suggest that IL-2 still can induce lymphocyte activation (30, 31) . Moreover, preliminary attempts to culture WAS patient NK cells in IL-2 resulted in some normalization of cytolytic activity (unpublished data), and, thus, in vitro IL-2 stimulation was avoided in trying to assess the role of WASp in NK cells. Because IL-2 can induce activation of cells with WASp mutations, IL-2 may promote cytoskeletal rearrangement independently of WASp. Thus, temporal and even spatial events in cultured cells might differ markedly from those in an unstimulated NK cell encountering a susceptible target. The effects of IL-2 on Cyt-D-treated NK cells have not been evaluated, but, presumably, the direct effect of this inhibitor on actin would prevent IL-2 from overcoming Cyt-D-mediated inhibition.
A difference between synaptic localization of WASp͞F-actin and perforin in normal cells was demonstrated. Even though 82% of NK cell͞target cell conjugates had F-actin and 72% had WASp at the IS, perforin was found to localize to the synapse in only 43% (Fig.  4) . Perforin accumulation was also concomitantly decreased in NK cells with impaired actin polymerization resulting from Cyt-D treatment. Actin cytoskeletal rearrangements, therefore, probably precede perforin mobilization. If the purpose of cytoskeletal rearrangement is to allow approximation of lipid raft domains and signaling partners (11) , perhaps only signals generated after actin reorganization result in perforin mobilization. Conversely, organization of microtubule structures presumably important in granule movements (32) might occur as an independent and slower process. The former model, however, is suggested by the demonstrated requirement for actin polymerization and WASp function both in NK cell cytotoxic activity and perforin mobilization to the NK cell-activating IS.
Thus, WASp is expressed in human NK cells and localizes to the activating IS with F-actin, and intact WASp function is required for NK cell cytotoxicity. Patients with WASP mutations and treatment with cytochalasin D, an actin-depolymerizing agent, demonstrate the importance of cytoskeletal activation and reorganization in the activation of NK cells. Moreover, the present data reinforce the conclusion that formation of the activating and inhibitory NK cell IS occurs by fundamentally distinct mechanisms, the actin cytoskeleton being required for the former, as shown here, but not for the latter synapse (15, 17) .
